Related Experiment Video

Updated: Jun 21, 2026

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
06:30

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats

Published on: September 11, 2018

The sympathetic nervous system and pathophysiology of congestive heart failure

John Farmer1

  • 1Department of Medicine-Cardiology, Baylor College of Medicine, Houston, TX 77030, USA. jfarmer@bcm.tmc.edu

Postgraduate Medicine
|August 12, 2009
PubMed

Insights

The sympathetic nervous system plays a key role in congestive heart failure progression. Beta-blockade therapy can improve heart function and slow disease advancement.

Area of Science:

  • Cardiology
  • Heart Failure Pathophysiology
  • Pharmacology

Background:

  • Congestive heart failure (CHF) understanding evolved from the hemodynamic hypothesis to the neurohormonal hypothesis.
  • The hemodynamic hypothesis focused on the heart's pumping ability as the primary issue in CHF.
  • The neurohormonal hypothesis highlights the detrimental effects of sympathetic nervous system activation on the myocardium in CHF.

Purpose of the Study:

  • To elucidate the role of the sympathetic nervous system in the progression of congestive heart failure.
  • To discuss the therapeutic application of beta-blockade in managing CHF.

Main Methods:

  • Review of existing literature on CHF pathophysiology.
  • Analysis of the impact of sympathetic nervous system activation on myocardial function.
  • Examination of clinical evidence for beta-blocker efficacy in CHF.

Main Results:

  • Sympathetic nervous system activation contributes significantly to adverse myocardial remodeling and dysfunction in CHF.
  • Beta-blockade effectively counteracts the deleterious effects of sympathetic overactivity.
  • Treatment with beta-blockers improves hemodynamic parameters and slows disease progression in CHF patients.

Conclusions:

  • The neurohormonal hypothesis provides a more comprehensive understanding of CHF progression.
  • Targeting the sympathetic nervous system with beta-blockade is a crucial strategy in CHF management.
  • Beta-blockade offers significant benefits for both hemodynamics and long-term outcomes in congestive heart failure.

More Related Videos

Surgical Lumbar Sympathectomy in Mice05:24

Surgical Lumbar Sympathectomy in Mice

Published on: July 5, 2024

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...